Trial · NCT00525421
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline to Two Weeks in Symptoms and Signs of Oral Lichen Planus (OLP) | Curcuminoid | NRS | -22 | Inter-Quartile Range -33 to -14 | percent change |
| Percent Change From Baseline to Two Weeks in Symptoms and Signs of Oral Lichen Planus (OLP) | Placebo | NRS | 0 | Inter-Quartile Range -29 to 16.7 | percent change |
| Percent Change From Baseline to Two Weeks in Symptoms and Signs of Oral Lichen Planus (OLP) | Curcuminoid | Erythema | -17 | Inter-Quartile Range -29 to -8.3 | percent change |
| Percent Change From Baseline to Two Weeks in Symptoms and Signs of Oral Lichen Planus (OLP) | Placebo | Erythema | 0 | Inter-Quartile Range -10 to 16.7 | percent change |
| Percent Change From Baseline to Two Weeks in Symptoms and Signs of Oral Lichen Planus (OLP) | Curcuminoid | Ulceration | -14 | Inter-Quartile Range -60 to 0 | percent change |
| Percent Change From Baseline to Two Weeks in Symptoms and Signs of Oral Lichen Planus (OLP) | Placebo | Ulceration | 0 | Inter-Quartile Range 0 to 26.7 | percent change |
| Percent Change From Baseline to Two Weeks in Symptoms and Signs of Oral Lichen Planus (OLP) | Curcuminoid | MOMI | -24 | Inter-Quartile Range -38 to -11 | percent change |
| Percent Change From Baseline to Two Weeks in Symptoms and Signs of Oral Lichen Planus (OLP) | Placebo | MOMI | -3.2 | Inter-Quartile Range -13 to 9.09 | percent change |
| Change in Serum C-reactive Protein and Serum Interleukin-6 Levels | Curcuminoid | CRP | 0 | Inter-Quartile Range -21 to 19 | Percent change |
| Change in Serum C-reactive Protein and Serum Interleukin-6 Levels | Placebo | CRP | 33.3 | Inter-Quartile Range 0 to 50 | Percent change |
| Change in Serum C-reactive Protein and Serum Interleukin-6 Levels | Curcuminoid | IL-6 | 20.3 | Inter-Quartile Range -16 to 60.6 | Percent change |
| Change in Serum C-reactive Protein and Serum Interleukin-6 Levels | Placebo | IL-6 | -1.6 | Inter-Quartile Range -6.1 to 3.17 | Percent change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00525421/results